CHICAGO UROLOGICAL SOCIETY (EIN 237071052) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Legal Domicile

Principal Officer

Gopal Nand Gupta MD FACS

Phone

8475177225

Tax Period

2023-08-01 to 2024-07-31

CHICAGO UROLOGICAL SOCIETY is a small nonprofit in the Diseases & Disorders sector that reported $268K in total revenue in fiscal year 2017. The organization ran a surplus of $56K, a strong 21% operating margin.

Mission

Seminars in the field of urology.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $199,386

Investment Income $0

Other Revenue $0

TOTAL REVENUE $199,386

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $190,352

TOTAL EXPENSES $190,352

Year-over-Year Comparison

	2023	2022	Change
Revenue	$199,386	$184,428	+0.1%
Expenses	$190,352	$222,013	-0.1%
Net Income	$9,034	$-37,585	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Gopal Nand Gupta MD FACS	President	1.00	Officer Director	$0	$0	$0
Sarah A Adelstein MD	Vice President	1.00	Officer Director	$0	$0	$0
Mark A Wille MD FACS	Treasurer	1.00	Officer Director	$0	$0	$0
Norm D Smith MD	PAST PRESIDENT	1.00	Officer Director	$0	$0	$0
Larissa Bresler MD DABMA	Director	1.00	Director	$0	$0	$0
Allen M Chernoff MD	Director	1.00	Director	$0	$0	$0
Christopher L Coogan MD	Director	1.00	Director	$0	$0	$0
Bejan Fakouri MD	Director	1.00	Director	$0	$0	$0
Irving S Garlovsky MD	Director	1.00	Director	$0	$0	$0
Daniel Garvey MD	Director	1.00	Director	$0	$0	$0
Laurence J Gott MD	Director	1.00	Director	$0	$0	$0
James Hanley Griffin MD	Director	1.00	Director	$0	$0	$0
Gordon J Kinzler MD	Director	1.00	Director	$0	$0	$0
Tamra Elizabeth LewisMD FACS	Director	1.00	Director	$0	$0	$0
William Wei Lin MD	Director	1.00	Director	$0	$0	$0
Fenwa Milhouse MD FPMRS	Director	1.00	Director	$0	$0	$0
Marcus L Quek MD	Director	1.00	Director	$0	$0	$0
Mark Jonathan Schacht MD	Director	1.00	Director	$0	$0	$0
Charles Oliver Turk DO	Director	1.00	Director	$0	$0	$0
Thomas MT Turk MD	Director	1.00	Director	$0	$0	$0
Paul Matthew Yonover MD FACS	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$199,386	$190,352	$1,094,805	$9,034
2023	$184,428	$222,013	$1,104,267	$-37,585
2022	$167,825	$190,200	$1,087,176	$-22,375
2021	$90,263	$52,737	$1,171,528	$37,526
2020	$235,887	$198,170	$1,068,590	$37,717
2019	$250,830	$224,184	$1,006,420	$26,646
2018	$268,086	$211,627	$965,567	$56,459

CHICAGO UROLOGICAL SOCIETY